Loss of scotopic contrast sensitivity in the optomotor response of diabetic mice

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 2, 2013, Pages 1536-1543

  Umino, Yumiko ^a   Solessio, Eduardo ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DARK ADAPTATION; GLYCEMIC CONTROL; GRATING; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VISUAL STIMULATION; VISUOMOTOR COORDINATION;

AGING; ANIMALS; BLOOD GLUCOSE; CONTRAST SENSITIVITY; DARK ADAPTATION; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DRUG IMPLANTS; HYPERGLYCEMIA; INSULIN; MALE; MICE; MICE, INBRED C57BL; MOTOR NEURONS; NIGHT VISION; PSYCHOMOTOR PERFORMANCE; VISUAL PATHWAYS;

EID: 84874952652     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10825     Document Type: Article

References (56)

1. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227-1239.
2. Gardner TW, Abcouwer SF, Barber AJ, Jackson GR. An integrated approach to diabetic retinopathy research. Arch Ophthalmol. 2011;129:230-235.
3. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 2003;26:2653-2664.
4. Jackson GR, Barber AJ. Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep. 2010;10:380-384.
5. Jackson GR, Scott IU, Quillen DA, Walter LE, Gardner TW. Inner retinal visual dysfunction is a sensitive marker of nonproliferative diabetic retinopathy. Br J Ophthalmol. 2012;96: 699-703.
6. Holopigian K, Seiple W, Lorenzo M, Carr R. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992;33: 2773-2780.
7. Abraham FA, Haimovitz J, Berezin M. The photopic and scotopic visual thresholds in diabetics without diabetic retinopathy. Metab Pediatr Syst Ophthalmol. 1988;11:76-77.
8. Greenstein VC, Thomas SR, Blaustein H, Koenig K, Carr RE. Effects of early diabetic retinopathy on rod system sensitivity. Optom Vis Sci. 1993;70:18-23.
9. Ewing FM, Deary IJ, Strachan MW, Frier BM. Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision. Endocr Rev. 1998; 19:462-476.
10. Wachtmeister L. Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res. 1998;17:485-521.
11. Tzekov R, Arden GB. The electroretinogram in diabetic retinopathy. Surv Ophthalmol. 1999;44:53-60.
12. VanGuilder H, Gardner T, Barber A. Neuroglial dysfunction in diabetic retinopathy. In: Duh E, ed. Diabetic Retinopathy. Totowa, NJ: Humana Press; 2008.
13. Shapley R, Enroth-Cugell C, Bonds AB, Kirby A. Gain control in the retina and retinal dynamics. Nature. 1972;236:352-353.
14. Di Leo MA, Caputo S, Falsini B, et al. Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care. 1992;15:620-625.
15. Shapley R, Enroth-Cugell C. Visual adaptation and retinal gain controls. Prog Retin Eye Res. 1984;3:263-346.
16. West SK, Rubin GS, Broman AT, Munoz B, Bandeen-Roche K, Turano K. How does visual impairment affect performance on tasks of everyday life? The SEE Project. Salisbury Eye Evaluation. Arch Ophthalmol. 2002;120:774-780.
17. Regan D, Neima D. Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson's disease. Br J Ophthalmol. 1984;68:885-889.
18. Della Sala S, Bertoni G, Somazzi L, Stubbe F, Wilkins AJ. Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment. Br J Ophthalmol. 1985;69:136-142.
19. Sokol S, Moskowitz A, Skarf B, Evans R, Molitch M, Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol. 1985;103:51-54.
20. Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology. 1988;95:693-698.
21. Harris A, Arend O, Danis RP, Evans D, Wolf S, Martin BJ. Hyperoxia improves contrast sensitivity in early diabetic retinopathy. Br J Ophthalmol. 1996;80:209-213.
22. Dosso AA, Bonvin ER, Morel Y, Golay A, Assal JP, Leuenberger PM. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 1996; 234:300-305.
23. Ismail GM, Whitaker D. Early detection of changes in visual function in diabetes mellitus. Ophthalmic Physiol Opt. 1998; 18:3-12.
24. Yoshioka M, Kayo T, Ikeda T, Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes. 1997;46:887-894.
25. Barber AJ, Antonetti DA, Kern TS, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46:2210-2218.
26. Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech. 2012;5:444-456.
27. Akimov NP, Renteria RC. Spatial frequency threshold and contrast sensitivity of an optomotor behavior are impaired in the Ins2Akita mouse model of diabetes. Behav Brain Res. 2012;226:601-605.
28. Prusky GT, Alam NM, Beekman S, Douglas RM. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci. 2004;45:4611-4616.
29. Umino Y, Solessio E, Barlow RB. Speed, spatial, and temporal tuning of rod and cone vision in mouse. J Neurosci. 2008;28: 189-198.
30. Umino Y, Frio B, Abbasi M, Barlow R. A two-alternative, forced choice method for assessing mouse vision. Adv Exp Med Biol. 2006;572:169-172.
31. Umino Y, Herrmann R, Chen C.-K, Barlow R, Arshavsky V, Solessio E. The relationship between slow photoresponse recovery rate and temporal resolution of vision. J Neurosci. 2012;32:14364-14373.
32. Brown ET, Umino Y, Loi T, Solessio E, Barlow R. Anesthesia can cause sustained hyperglycemia in C57/BL6J mice. Vis Neurosci. 2005;22:615-618.
33. Alexander JJ, Umino Y, Everhart D, et al. Restoration of cone vision in a mouse model of achromatopsia. Nat Med. 2007;13: 685-687.
34. Pang J, Boye SE, Lei B, et al. Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency. Gene Ther. 2010;17:815-826.
35. Jackson GR, Owsley C. Visual dysfunction, neurodegenerative diseases, and aging. Neurol Clin. 2003;21:709-728.
36. Klein R, Klein BE. Are individuals with diabetes seeing better? A long-term epidemiological perspective. Diabetes. 2010;59: 1853-1860.
37. Dunn FA, Doan T, Sampath AP, Rieke F. Controlling the gain of rod-mediated signals in the Mammalian retina. J Neurosci. 2006;26:3959-3970.
38. Abd-El-Barr MM, Pennesi ME, Saszik SM, et al. Genetic dissection of rod and cone pathways in the dark-adapted mouse retina. J Neurophysiol. 2009;102:1945-1955.
39. Pang JJ, Gao F, Lem J, Bramblett DE, Paul DL, Wu SM. Direct rod input to cone BCs and direct cone input to rod BCs challenge the traditional view of mammalian BC circuitry. Proc Natl Acad Sci U S A. 2010;107:395-400.
40. Bloomfield SA, Volgyi B. The diverse functional roles and regulation of neuronal gap junctions in the retina. Nat Rev Neurosci. 2009;10:495-506.
41. Famiglietti EV Jr, Kolb H. A bistratified amacrine cell and synaptic circuitry in the inner plexiform layer of the retina. Brain Res. 1975;84:293-300.
42. Enroth-Cugell C, Robson JG. The contrast sensitivity of retinal ganglion cells of the cat. J Physiol. 1966;187:517-552.
43. Hancock HA, Kraft TW. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci. 2004; 45:1002-1008.
44. Kohzaki K, Vingrys AJ, Bui BV. Early inner retinal dysfunction in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci. 2008;49:3595-3604.
45. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol. 2008;586:4401-4408.
46. Gastinger MJ, Kunselman AR, Conboy EE, Bronson SK, Barber AJ. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Invest Ophthalmol Vis Sci. 2008;49:2635-2642.
47. Gastinger MJ, Singh RS, Barber AJ. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci. 2006;47:3143-3150.
48. Smith SB, Duplantier J, Dun Y, et al. In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. Invest Ophthalmol Vis Sci. 2008;49:4154-4161.
49. He S, Levick WR. Spatial-temporal response characteristics of the ON-OFF direction selective ganglion cells in the rabbit retina. Neurosci Lett. 2000;285:25-28.
50. Simpson JI. The accessory optic system. Ann Rev Neurosci. 1984;7:13-41.
51. Sun W, Deng Q, Levick WR, He S. ON direction-selective ganglion cells in the mouse retina. J Physiol. 2006;576:197-202.
52. Xu Y, Dhingra NK, Smith RG, Sterling P. Sluggish and brisk ganglion cells detect contrast with similar sensitivity. J Neurophysiol. 2005;93:2388-2395.
53. Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res. 2002;74:615-625.
54. Phipps JA, Fletcher EL, Vingrys AJ. Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest Ophthalmol Vis Sci. 2004;45:4592-4600.
55. Kelly DH. Adaptation effects on spatio-temporal sine-wave thresholds. Vision Res. 1972;12:89-101.
56. van Nes FL, Koenderink JJ, Nas H, Bouman MA. Spatiotemporal modulation transfer in the human eye. J Opt Soc Am. 1967;57: 1082-1088.